Daily
250 words
4/10
Rating

28 June 2026

CGHS financial power enhancement

This is an administrative procedural update to an existing welfare scheme that serves as a useful example of governance reform and service delivery improvement, but it is not a major policy shift likely to be asked directly.

1 min read 1 questions 1 prelims

Notes

  • The Union Health Ministry has revised the delegation of financial powers for Central Government Health Scheme (CGHS) officials.
  • The objective is to expedite cashless treatment approvals, medical reimbursement claims, and sanctioning of unlisted investigations/procedures.
  • Revised reimbursement/bill approval limits: Additional Directors (up to ₹15 lakh, previously ₹7 lakh); Directors (up to ₹25 lakh, previously ₹15 lakh); Additional Secretary and DG (up to ₹50 lakh, previously ₹25 lakh).
  • Cases exceeding ₹50 lakh require approval from the Union Health Ministry with Integrated Finance Division concurrence.
  • Revised approval limits for unlisted investigations, procedures, and implants: Additional Directors (up to ₹2 lakh); Directors (up to ₹5 lakh); Additional Secretary and DG (up to ₹10 lakh).
  • The policy change aims to reduce administrative delays and benefit pensioners and elderly beneficiaries requiring tertiary care.

Questions

  1. Discuss the significance of decentralizing financial decision-making in public health schemes like the CGHS to improve service delivery and beneficiary welfare. 150 words
    Attempt this — 150 words in 8 min
    0 / 150 words 8:00

Prelims

  1. Under the revised financial powers for the Central Government Health Scheme (CGHS), what is the new approval limit for medical reimbursement claims for an Additional Secretary and DG?